SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

80,999.40 -28.62
( -0.04%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Onyx Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

93585

INE0WVU01018

30.5576819

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ONYX

62.74

EPS(TTM)

Face Value()

Div & Yield %

Back

genpharmasec limited

Regent Enterprises standalone net profit rises 54.27% in the June 2026 quarter

Aug 13,2026

Net profit of Regent Enterprises rose 54.27% to Rs 2.53 crore in the quarter ended June 2026 as against Rs 1.64 crore during the previous quarter ended June 2025. Sales declined 42.07% to Rs 138.27 crore in the quarter ended June 2026 as against Rs 238.67 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	138.27	238.67	-42
OPM %	1.27	0.74	-
PBDT	1.76	1.77	-1
PBT	1.63	1.64	-1
NP	2.53	1.64	54

80,999.40 -28.62 ( -0.04%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)